Delta Global Management LP Acquires 7,896 Shares in Penumbra, Inc.

The investment firm adds to its position in the medical device company.

Mar. 17, 2026 at 8:48am

Got story updates? Submit your updates here. ›

Delta Global Management LP acquired a new position in shares of Penumbra, Inc. (NYSE:PEN) during the third quarter, purchasing 7,896 shares of the company's stock valued at approximately $2,000,000. Several other hedge funds and institutional investors have also recently added to or reduced their stakes in Penumbra.

Why it matters

Penumbra is a leading medical device company that specializes in products for treating neurovascular and peripheral vascular conditions. The acquisition of a significant stake by Delta Global Management suggests the investment firm sees long-term growth potential in Penumbra's business and technology.

The details

Delta Global Management LP acquired the 7,896 shares of Penumbra, Inc. (NYSE:PEN) during the third quarter. The fund's new position in Penumbra is valued at approximately $2,000,000. Several other major institutional investors, including Thrivent Financial for Lutherans and the New York State Common Retirement Fund, have also recently adjusted their holdings in Penumbra.

  • Delta Global Management LP acquired the 7,896 Penumbra shares during the third quarter of the year.
  • Penumbra's stock price has ranged from a 12-month low of $221.26 to a high of $362.41.

The players

Delta Global Management LP

An investment management firm that has acquired a new position in shares of Penumbra, Inc.

Penumbra, Inc.

A global healthcare company specializing in the development and manufacture of innovative medical devices for treating neurovascular and peripheral vascular conditions.

Thrivent Financial for Lutherans

A major institutional investor that has increased its stake in Penumbra, Inc.

New York State Common Retirement Fund

A large institutional investor that has also adjusted its holdings in Penumbra, Inc.

Got photos? Submit your photos here. ›

The takeaway

The acquisition of a significant stake in Penumbra by Delta Global Management suggests the investment firm sees strong growth potential in the medical device company's innovative products and technology. Penumbra's stock has performed well over the past year, attracting interest from other major institutional investors as well.